Abstract 40: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine Model

Similar Items

• Abstract 47: AMD3100 (Plerixafor) As A Single-Dose Stem Cell Mobilizing Agent In Vascularized Composite Tissue Allograft (VCA) Transplantation In A Canine DLA-Mismatch Model
  od: Swearingen, Bruce J., i dr.
  Izdano: (2019)
• Abstract 48: A Clinically Relevant Protocol for Vascularized Composite Allotransplantation Using A Single Dose of AMD3100 for Stem Cell Mobilization
  od: Swearingen, Bruce J., i dr.
  Izdano: (2017)
• Turning CD34 Non-Mobilizers into Mobilizers: A Case Report Involving Plerixafor (AMD3100)
  od: Garritsen, Henk S.P., i dr.
  Izdano: (2009)
• Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model
  od: Burroughs, Lauri, i dr.
  Izdano: (2005)
• Long-Term Tolerance Towards Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells
  od: Chang, Jeff, i dr.
  Izdano: (2016)